Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Dimethyl Sulfoxide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethyl Sulfoxide SCHEMBL28959106 | 0.94 | — | — | |
| Dimethyl Sulfoxide SCHEMBL6975717 | 0.86 | — | — | |
| Dimethyl Sulfoxide SCHEMBL8088881 | 0.86 | — | — | |
| Dimethyl Sulfoxide SCHEMBL28146630 | 0.86 | — | — | |
| Dimethyl Sulfoxide SCHEMBL4753886 | 0.86 | — | — | |
| Dimethyl Sulfoxide SCHEMBL7036841 | 0.86 | GUSB (0.42) | — | |
| Dimethyl Sulfoxide SCHEMBL9147174 | 0.86 | — | — | |
| Dimethyl Sulfoxide SCHEMBL5162396 | 0.86 | GUSB (0.42) | — | |
| Dimethyl Sulfoxide SCHEMBL1096981 | 0.86 | — | — | |
| Dimethyl Sulfoxide SCHEMBL27873690 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116137301-A | Acid modified leadless perovskite solar cell and preparation method thereof | 长沙理工大学 | 2023-05-19 | — | — | CN | disclosed |
| EP-3613089-B1 | SEMICONDUCTOR DEVICE COMPRISING HALOPALLADATE | UNIV OXFORD INNOVATION LTD (GB) | 2022-03-23 | — | — | EP | disclosed |
| US-11282973-B2 | Semiconductor device comprising halopalladate | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2022-03-22 | — | — | US | disclosed |
| US-10899786-B2 | Nucleoside phosphate compound and preparation method and use thereof | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2021-01-26 | — | — | US | disclosed |
| US-20200308214-A1 | NUCLEOSIDE PHOSPHATE COMPOUND AND PREPARATION METHOD AND USE THEREOF | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2020-10-01 | — | — | US | disclosed |
| EP-3666265-A1 | IMPROVED COMPLEXES AND COMPOSITIONS CONTAINING CURCUMIN | Cave, Harold Gordon (NZ) | 2020-06-17 | — | — | EP | disclosed |
| EP-3613089-A1 | SEMICONDUCTOR DEVICE COMPRISING HALOPALLADATE | Oxford University Innovation Limited (GB) | 2020-02-26 | — | — | EP | disclosed |
| US-20200044102-A1 | SEMICONDUCTOR DEVICE COMPRISING HALOPALLADATE | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2020-02-06 | — | — | US | disclosed |
| EP-3560943-A1 | NUCLEOSIDE PHOSPHATE COMPOUND AND PREPARATION METHOD AND USE THEREOF | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) | 2019-10-30 | — | — | EP | disclosed |
| CN-107284068-B | Water-based ink is indoors and the method for outdoor inkjet printing design for advertisement | 孙铁宁 | 2019-08-09 | — | — | CN | disclosed |
| EP-2852395-A1 | IMPROVED COMPLEXES AND COMPOSITIONS CONTAINING CURCUMIN | Cave, Harold Gordon (NZ) | 2015-04-01 | — | — | EP | disclosed |
| US-8981156-B2 | Method for production of F-18 labeled amyloid beta ligands | PIRAMAL IMAGING SA (CH) | 2015-03-17 | — | — | US | disclosed |
| WO-2013176555-A1 | IMPROVED COMPLEXES AND COMPOSITIONS CONTAINING CURCUMIN | CAVE HAROLD GORDON (NZ) | 2013-11-28 | — | — | WO | disclosed |
| US-20130172620-A1 | METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS | PIRAMAL IMAGING SA (CH) | 2013-07-04 | — | — | US | disclosed |
| EP-2590683-A1 | METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS | Piramal Imaging SA (CH) | 2013-05-15 | — | — | EP | disclosed |
| WO-2011151273-A1 | METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2011-12-08 | — | — | WO | disclosed |
| US-7601512-B2 | Methods for identifying inhibitors of the 20S and 26S proteasome | BAYER CROPSCIENCE AG (DE) | 2009-10-13 | — | — | US | disclosed |
| US-20040053312-A1 | Methods for identifying inhibitors of the 20S and 26S proteasome | BAYER CROPSCIENCE AG (DE) | 2004-03-18 | — | — | US | disclosed |
| WO-2003009834-A1 | ORAL DELIVERY OF PHARMACEUTICALS VIA ENCAPSULATION | BATTEY ALYCE S (US) | 2003-02-06 | — | — | WO | disclosed |
| US-20020022057-A1 | Oral delivery of pharmaceuticals via encapsulation | BATTEY ALYCE S (US) | 2002-02-21 | — | — | US | disclosed |